Background Aspartate aminotransferase-to-platelet ratio index (APRi) may be useful
noninvasive prognostic tool in biliary atresia (BA). We studied whether APRi predicts native …

BACKGROUND: Biliary atresia (BA) is a progressive obliterative cholangiopathy leading to
liver fibrosis and cirrhosis. The aspartate aminotransferase-to-platelet ratio index (APRi) has …

Aims The outcomes following surgical treatment of infants with biliary atresia (BA) varies
across the world with many possible confounding factors. APRi (AST-to-platelet ratio index) …

Background: In patients with biliary atresia (BA), liver fibrosis and cirrhosis commonly occur
even after Kasai hepatoportoenterostomy. Although liver biopsy is the gold standard to …

AIM: To validate the value of aspartate aminotransferase to platelet ratio index (APRI) in
assessment of liver fibrosis and prediction of postoperative prognosis of biliary atresia (BA) …

Kim et al (1) postulating that the aspartate transaminaseto-platelet ratio index (APRI) can be
used as a noninvasive, easily available surrogate marker for the severity of liver fibrosis in …

Objectives: Biliary atresia (BA), a congenital idiopathic obliterative cholangiopathy, rapidly
leads to liver cirrhosis and liver failure if untreated. A timely Kasai portoenterostomy (KP) …

Background/purpose The role of serum gamma-glutamyl transpeptidase (GGT) levels in
predicting clinical outcomes after Kasai portoenterostomy (KPE) is unknown. This study …

Purpose Total bilirubin (T-bil) is used universally for monitoring post-portoenterostomy (PE)
biliary atresia (BA) patients although other biochemical markers [BM; AST/ALT and platelet …

Background To determine a very early predictive biomarker after hepatoportoenterostomy
(HPE) for the prediction of native liver survival in biliary atresia (BA) patients. Methods A …